26 February 2019, Oxford, UK
25 scientists from 12 institutes across 5 countries joined Prof Susie Dunachie for this highly successful workshop discussing the roadmap to first-in-man melioidosis vaccine clinical trials and the lessons learned in the TB field when moving vaccine candidates from animals to humans.
VALIDATE members can access the workshop slides and video on our Resources portal.
Description of the workshop
VALIDATE and Prof Susanna Dunachie are hosting a Melioidosis Vaccine Symposium entitled “Moving from animal models to man” on the afternoon of Tuesday 26 February 2019 at the University of Oxford, UK, where we will be discussing the roadmap to first-in-man melioidosis vaccine clinical trials and the lessons learned in the TB field when moving vaccine candidates from animals to humans. We would like to open this workshop to any VALIDATE members who would find it of use and interest.
12.30: Networking lunch
13.30: Introduction (Prof Helen Fletcher, LSHTM, Co-Director of VALIDATE)
13.45 The prospect of a melioidosis vaccine (Prof Susanna Dunachie, University of Oxford)
14.15: Lessons from the TB vaccine pipeline and immune-monitoring (Prof Helen Fletcher)
14.45: The DTRA funding portfolio for Burkholderia (Dr Julie Boylan, DTRA) - presentation was confidential and so slides and video are not available for this talk.
15:30 Candidates and next steps (Assoc Prof Paul Brett, University of Nevada)
16.45: Concluding remarks